Stalwarts

STALWARTS

Traits
• Growth rate = 2x GNP growth rate
• Growth Rates: Slow Growers (1x GNP) <
Stalwarts (2x GNP) < Fast Growers (20-25%)
• Fairly large sized companies
• You can profit, based on time and price of
purchase. Long term return will be = bonds
• Good performers, but not stars – 50% return
in 2 years is a delightful result. Sell more
readily than Fast Growers.
• Good performers in good markets. Take 30-
50% returns, and then rotate money into
another Stalwart.
• Operating performance of such defensives
helps them survive recessions. No down
quarter for 20-30 years.
• Offer good protection in hard times. Won’t go
bankrupt, soon enough they’ll be
reassessed, and their value will be restored.
• Don’t hold after 2x, hoping for 10x. Can hold
for 20 years only if you bought a “Great”
company at a “Good” price.
• Can hardly go wrong by making a full
portfolio of companies that have raised
dividends for 10-20 years in a row.
• Hidden assets like brands & patents grow
larger, while the company punishes P&L
EPS via amortization, R&D, branding etc.
EPS will jump when these expenses stop, or,
the new product hits the market.
o Due to these hidden assets and low
maintenance capex, FCF > EPS.
o Possible to cut costs, raise prices and
also capture market share in slow growth
markets.
o If you can find a company that can raise
prices without losing customers, you’ve
found a terrific investment.

Examples
• Pharma, Tobacco, FMCG, Alcohol

People Examples
• Command good salaries and get predictable
raises – mid level employees

PE Ratio
• Average = 10-14x.
• PEG <0.5-1x is fine, but 2x is expensive.

2 Minute Drill
• Key issues are PE, recent price run-ups, and
what, if anything is happening to accentuate
growth rate?
• Coke is selling at the low end of its PE range.
Stock hasn’t gone anywhere for 2 years, even
though the company has improved in many
ways. Sold 50% of Columbia Pictures. Diet
drinks have dramatically sped up growth
rate. Foreign sales are excellent. Has better
control over sales & distribution after buying
out many independent, regional distributors.
Thus, it may do better than people think.

Checklist
• Price = key issue, since these are big
companies that aren’t likely to go out of
business
• Diworseification – capital misallocation may
reduce future earnings. Board of Directors’
is better off returning cash to shareholders.
• Long Term Growth Rate – has company kept
up with growth rate momentum in recent
years? Is it slowing/speeding?
• Long Term Holding – how did it fare during
previous recessions / market correction?

Portfolio Allocation %
• 10-20% Allocation, in order to moderate
risks in portfolio full of Fast Growers and
Turnarounds.
• Average 20% Allocation in a personal
investor’s 10 stock portfolio.

Risk/Reward
• Low Risk – Moderate Gain.
• 2 year hold may give 50% upside vs 20%
downside.
• 6 rotations of 25-30% CAGR Stalwarts = 4-
5x, or 1 big winner.

Sell When
• Stalwarts with heavy institutional ownership
and lots of Wall Street coverage, that have
outperformed the market and are overpriced,
are due for a rest or decline.
• 10x not possible. If P>E, or, PE>Normal, sell
and rotate. If Price gets ahead, but the story
is still the same, sell and rotate.
• New products of last 2 years have mixed
results & new testing products are >1 year
from market launch
• PE = 15x, vs similar quality company from
same industry at 11-12x PE
• No Executive/CXO/Director has bought
shares in last 1 year
• Large division (>25% of sales) is vulnerable
to an ongoing economic slump (housing, oil)
• Growth rate is slowing down and though
earnings have been maintained via cost
cuts, there’s no further room left.